Multidrug Resistance in the 2020's: A Threat in the Hospital and in the Community
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 4434
Special Issue Editors
Interests: critical care; infectious diseases; sepsis; healthcare-associated infections; severe respiratory infections; multidrug-resistant microorganisms; antibiotic optimization; high fidelity medical simulation
Special Issues, Collections and Topics in MDPI journals
Interests: clinical epidemiology of severe infections in critically ill patients; infection prevention; education in quality improvement interventions
Special Issue Information
Dear Colleagues,
Multidrug Resistance represent a major concern for public health and the pressure for hospitals and communities. During the ongoing COVID-19 pandemic, antibiotics and antifungals have been extensively used for the management of hospitalized patients infected with SARS-CoV-2. Unintended consequences of antimicrobial overuse include, among others, the increment of resistance and the circulation of multidrug-resistant organisms (MDROs). On the other hand, the management of hospitalized SARS-CoV-2 patients increases the risk of outbreak due to MDROs for several reasons, including the increased number of patients, increased length of hospital stay, extensive antibiotic use, lack of infection prevention and control measures and interruption of antimicrobial stewardship programs.
In this Special Issue, we encourage colleagues to submit manuscripts related to the multidrug-resistant pathogens and relevant treatment—from hospital to communities. We also welcome manuscripts describing new methods and the adaption or creation of technologies for the study, prevention, and control of multidrug resistance.
Dr. Despoina Koulenti
Prof. Dr. Stijn Blot
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug resistance
- antibiotics
- antifungals
- multidrug resistant pathogen